Log in or Sign up for Free to view tailored content for your specialty!
Schizophrenia News
Positive results in phase 2 trial of add-on drug for treatment-resistant schizophrenia
A biopharmaceutical company has announced positive topline results from its phase 2, randomized, open-label trial of evenamide as an add-on to antipsychotic medication in those with moderate to severe treatment-resistant schizophrenia.
Motivational interview, CBT combination improves schizophrenia symptoms
Combining motivational interviews with cognitive behavioral therapy improved negative symptoms of schizophrenia compared with mindfulness sessions, according to findings published in The American Journal of Psychiatry.
Log in or Sign up for Free to view tailored content for your specialty!
Inaugural cohort announced for startup collaboration on mental health initiatives
A mental health nonprofit has announced 11 companies will make up the inaugural cohort of a program that aims to help startups improve the lives of those with challenges relating to mental health conditions.
Accord Healthcare to offer generic schizophrenia, bipolar depression drug
A generic pharmaceutical company announced the availability of a schizophrenia and bipolar depression treatment, according to a press release.
Psychiatric visits 146% higher for patients in year before MS onset
SAN DIEGO — Patients with MS were twice as likely to experience psychiatric morbidity, including depression and anxiety, in the prodromal phase compared with healthy controls, according to research presented at ACTRIMS 2023.
Nonadherence, switching, stopping antipsychotics linked to more acute care utilization
For individuals prescribed antipsychotic medication, nonadherence, along with switching and stopping medication, was associated with increases in acute care utilization, according to a study published in BMC Psychiatry.
Impaired motor skills may indicate psychosis for kids in families with psych disorders
In children with familial high risk of schizophrenia or bipolar disorder, evidence of motor impairment skills may indicate neurodevelopmental vulnerability for psychosis.
Needs of family members unmet with parent hospitalization for mental illness
The needs of families are largely unmet when a parent is hospitalized for a mental illness, with the need for a broad range of care models required to address these gaps, according to a study published in BMC Psychiatry.
Affordable Care Act provisions reduced percentage of uninsured people with schizophrenia
The percentage of those with schizophrenia who were uninsured decreased after the Affordable Care Act provisions were implemented, researchers reported in JAMA Psychiatry.
FDA approves schizophrenia, bipolar treatment
The FDA has approved Rykindo for extended-release injectable suspension for the treatment of schizophrenia, as well as monotherapy or adjunctive therapy for the maintenance treatment of bipolar 1 disorder in adults.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read